Trial
NCT02941601
A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Locally Advanced Squamous Non-Small Cell Lung Cancer
Intervention
Necitumumab
Why stopped
This was a strategic decision for business planning purposes and not out of concern for patient safety.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-27